Home>
US Stocks>
Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc share price today

(ABOS)

Acumen Pharmaceuticals Inc share price is $2.16 & ₹182.93 as on 7 Dec 2024, 2.30 'hrs' IST

$2.16

▲

0.04

(1.89%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Acumen Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Acumen Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Acumen Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Acumen Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Acumen Pharmaceuticals Inc's financials.

Acumen Pharmaceuticals Inc share price movements

$2.12
$2.18
$2.16
1.85%
Downside
Day's Volatility :2.75%
Upside
0.92%
$2.08
$5.09
$2.16
3.7%
Downside
52 Weeks Volatility :59.14%
Upside
57.56%

Acumen Pharmaceuticals Inc Returns

Period	Acumen Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-13.11%	-5.7%	0.0%
6 Months	-19.08%	-0.9%	0.0%
1 Year	-23.47%	10.0%	0.0%
3 Years	-72.14%	9.3%	-21.5%

Acumen Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$2.12
Open	$2.12
Today's High	$2.18
Today's Low	$2.12
Market Capitalization	$136.4M
Today's Volume	$291.4K
52 Week High	$5.09
52 Week Low	$2.08
Revenue TTM	$329.0K
EBITDA	$-92.8M
Earnings Per Share (EPS)	$-1.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-32.83%

How to invest in Acumen Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Acumen Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acumen Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Acumen Pharmaceuticals Inc or ABOS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acumen Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acumen Pharmaceuticals Inc shares which would translate to 0.392 fractional shares of Acumen Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Acumen Pharmaceuticals Inc

160%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Acumen Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 160% more investors are searching Acumen Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Acumen Pharmaceuticals Inc

RA Capital Management, LLC
24.85%
Franklin Resources Inc
5.91%
Sands Capital Ventures, LLC
5.69%
Rock Springs Capital Management LP
3.83%
BlackRock Inc
3.59%
FMR Inc
3.38%

Analyst Recommendation on Acumen Pharmaceuticals Inc

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Acumen Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Acumen Pharmaceuticals Inc

What analysts predicted

Upside of 400.0%

Current:

$2.16

Target:

$10.80

Insights on Acumen Pharmaceuticals Inc

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 66.7%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 111.6%

Acumen Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Acumen Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Acumen Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Acumen Pharmaceuticals Inc	-33.12%	-19.08%	-23.47%	-72.14%	-88.78%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	10.16%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Acumen Pharmaceuticals Inc	3.26	NA	NA	-1.48	-0.33	-0.21	NA	3.62
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Acumen Pharmaceuticals Inc	Buy	$136.4M	-88.78%	3.26	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Acumen Pharmaceuticals Inc

acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (aβo) in synaptic dysfunction and neurodegeneration. these early insights have fostered decades of research on the biology of aβo at acumen and throughout the field. we are now on the on cusp of realizing the therapeutic potential of aβo targeted drugs.

Organization	Acumen Pharmaceuticals Inc
Employees	51
CEO	Mr. Daniel J. O'Connell M.B.A.
Industry	Healthcare

Management People of Acumen Pharmaceuticals Inc

Name	Title
Mr. Daniel J. O'Connell M.B.A.	CEO & Director
Mr. Matt Zuga	CFO & Chief Business Officer
Mr. Derek M. Meisner Esq., J.D.	Chief Legal Officer & Corporate Secretary
Dr. James Doherty Ph.D.	President & Chief Development Officer
Dr. Grant A. Krafft Ph.D.	Co-Founder
Dr. Caleb E. Finch Ph.D.	Co-Founder
Dr. William L. Klein Ph.D.	Co-Founder
Mr. Russell Barton M.S.	Chief Operating Officer
Ms. Kelly Carranza	Vice President, Finance & Accounting and Corporate Controller
Ms. Alex Braun M.B.A.	VP & Head of Investor Relations

Important FAQs about investing in Acumen Pharmaceuticals Inc from India :

What is Acumen Pharmaceuticals Inc share price today?

Acumen Pharmaceuticals Inc (ABOS) share price today is $2.16.

Can Indians buy Acumen Pharmaceuticals Inc shares?

Yes, Indians can invest in the Acumen Pharmaceuticals Inc (ABOS) from India.

With INDmoney, you can buy Acumen Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Acumen Pharmaceuticals Inc at zero transaction cost.

How can I buy Acumen Pharmaceuticals Inc shares from India?

It is very easy to buy Acumen Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acumen Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Acumen Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Acumen Pharmaceuticals Inc stocks?

To start investing in Acumen Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.